408 related articles for article (PubMed ID: 1347332)
1. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
3. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
6. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
7. Clinical review of lansoprazole.
Lockhart SP
Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
[TBL] [Abstract][Full Text] [Related]
8. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
11. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
12. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Tsuji S; Kawano S; Higashi T; Mukuda T; Imaizumi T; Tatsumi T; Miura N; Miyajima K; Fukuda M; Noguchi M
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-4. PubMed ID: 7594320
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
Yukawa K; Yukawa E
Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
[TBL] [Abstract][Full Text] [Related]
16. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
17. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
18. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
Pei Y; Wang B; Chen S
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
[TBL] [Abstract][Full Text] [Related]
19. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
Endo M; Sugihara K
Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817
[TBL] [Abstract][Full Text] [Related]
20. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
